Clinical Trials Browser

Neoplasms × ProMune × Clear all

NCT00199836 2022-10-10

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

Phase 1 Completed

14 enrolled 11 charts

Neoplasms

NCT00031278 2011-05-30

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Phase 1/2 Completed

Carcinoma, Neoplasm Metastasis, Neoplasms